NLRP3 and gastric cancer: This repression enhances cisplatin resistance in TAMs.468 Moreover, during gastric carcinogenesis, Helicobacter pylori suppresses the expression of miR-22 in gastric mucosa, weakening its inhibitory effect on NLRP3 and thus promoting gastric cancer progression.436